Pegvisomant PEG-V editSet type / Edit
«Pegvisomant (trade name Somavert) is a growth hormone receptorantagonist used in the treatment of acromegaly. It is primarily used if the pituitary gland tumor causing the acromegaly cannot be controlled with surgery or radiation, and the use of somatostatin analogues is unsuccessful, but is also effective as a monotherapy. It is delivered as a powder that is mixed with water and injected under the skin.» (wikipedia)
Modified: 3 months ago on May 17, 2019
3 months ago on May 12, 2019.